FMS logo

Fresenius Medical Care AG (FMS) EBITDA

Annual EBITDA:

$3.44B-$20.25M(-0.59%)
December 31, 2024

Summary

  • As of today, FMS annual EBITDA is $3.44 billion, with the most recent change of -$20.25 million (-0.59%) on December 31, 2024.
  • During the last 3 years, FMS annual EBITDA has fallen by -$796.60 million (-18.81%).
  • FMS annual EBITDA is now -20.54% below its all-time high of $4.33 billion, reached on December 31, 2020.

Performance

FMS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFMSincome statement metrics

Quarterly EBITDA:

$1.00B+$139.09M(+16.14%)
September 30, 2025

Summary

  • As of today, FMS quarterly EBITDA is $1.00 billion, with the most recent change of +$139.09 million (+16.14%) on September 30, 2025.
  • Over the past year, FMS quarterly EBITDA has increased by +$214.40 million (+27.27%).
  • FMS quarterly EBITDA is now -15.90% below its all-time high of $1.19 billion, reached on December 31, 2020.

Performance

FMS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFMSincome statement metrics

TTM EBITDA:

$3.69B+$214.40M(+6.16%)
September 30, 2025

Summary

  • As of today, FMS TTM EBITDA is $3.69 billion, with the most recent change of +$214.40 million (+6.16%) on September 30, 2025.
  • Over the past year, FMS TTM EBITDA has increased by +$247.92 million (+7.20%).
  • FMS TTM EBITDA is now -18.39% below its all-time high of $4.53 billion, reached on March 31, 2021.

Performance

FMS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFMSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

FMS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-0.6%+27.3%+7.2%
3Y3 Years-18.8%+22.8%+4.4%
5Y5 Years-16.8%-14.2%-17.4%

FMS EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-18.8%at low-0.5%+27.3%at high+12.4%
5Y5-Year-20.5%at low-15.9%+27.3%-18.4%+12.4%
All-TimeAll-Time-20.5%+1119.4%-15.9%+147.7%-18.4%+546.0%

FMS EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.00B(+16.1%)
$3.69B(+6.2%)
Jun 2025
-
$861.52M(+4.4%)
$3.48B(+2.0%)
Mar 2025
-
$825.31M(-18.0%)
$3.41B(-3.2%)
Dec 2024
$3.44B(-0.6%)
$1.01B(+27.9%)
$3.52B(+2.2%)
Sep 2024
-
$786.21M(-0.8%)
$3.45B(-3.5%)
Jun 2024
-
$792.82M(-15.3%)
$3.57B(-2.1%)
Mar 2024
-
$936.28M(+0.7%)
$3.65B(+3.0%)
Dec 2023
$3.46B(-5.2%)
$930.17M(+2.3%)
$3.54B(+2.5%)
Sep 2023
-
$909.65M(+4.6%)
$3.45B(+2.8%)
Jun 2023
-
$869.57M(+4.5%)
$3.36B(+2.2%)
Mar 2023
-
$831.80M(-1.3%)
$3.29B(-0.5%)
Dec 2022
$3.65B(-13.8%)
$842.56M(+3.4%)
$3.30B(-6.6%)
Sep 2022
-
$814.92M(+2.3%)
$3.54B(-6.1%)
Jun 2022
-
$796.79M(-6.1%)
$3.77B(-4.2%)
Mar 2022
-
$848.26M(-21.2%)
$3.93B(-3.8%)
Dec 2021
$4.24B(-2.1%)
$1.08B(+3.0%)
$4.09B(-2.7%)
Sep 2021
-
$1.04B(+8.7%)
$4.20B(-2.8%)
Jun 2021
-
$961.28M(-4.4%)
$4.32B(-4.5%)
Mar 2021
-
$1.01B(-15.5%)
$4.53B(+0.0%)
Dec 2020
$4.33B(+4.7%)
$1.19B(+2.1%)
$4.52B(+1.2%)
Sep 2020
-
$1.17B(+0.1%)
$4.47B(+1.7%)
Jun 2020
-
$1.16B(+16.1%)
$4.39B(+4.3%)
Mar 2020
-
$1.00B(-11.6%)
$4.21B(+0.1%)
Dec 2019
$4.13B(+14.4%)
$1.13B(+4.0%)
$4.21B(+5.4%)
Sep 2019
-
$1.09B(+11.1%)
$3.99B(+8.2%)
Jun 2019
-
$982.50M(-1.5%)
$3.69B(+3.1%)
Mar 2019
-
$997.95M(+8.8%)
$3.57B(+5.7%)
Dec 2018
$3.61B(-2.0%)
$917.42M(+16.4%)
$3.38B(+3.4%)
Sep 2018
-
$788.26M(-9.5%)
$3.27B(-3.5%)
Jun 2018
-
$871.32M(+8.4%)
$3.39B(+1.5%)
Mar 2018
-
$803.73M(-0.3%)
$3.34B(-2.3%)
Dec 2017
$3.69B(+9.5%)
$806.48M(-11.2%)
$3.42B(-5.0%)
Sep 2017
-
$908.14M(+10.5%)
$3.60B(+1.6%)
Jun 2017
-
$822.11M(-6.7%)
$3.54B(-0.4%)
Mar 2017
-
$880.68M(-10.6%)
$3.55B(+5.2%)
Dec 2016
$3.37B(+8.1%)
$984.97M(+15.7%)
$3.38B(+4.7%)
Sep 2016
-
$851.00M(+1.8%)
$3.22B(+2.1%)
Jun 2016
-
$836.19M(+18.9%)
$3.16B(+3.8%)
Mar 2016
-
$703.50M(-15.6%)
$3.04B(+1.7%)
Dec 2015
$3.12B(+10.7%)
$834.00M(+6.3%)
$2.99B(+3.1%)
Sep 2015
-
$784.33M(+8.8%)
$2.90B(+2.2%)
Jun 2015
-
$721.13M(+10.6%)
$2.84B(-0.6%)
Mar 2015
-
$652.01M(-12.3%)
$2.86B(+1.4%)
Dec 2014
$2.81B(-1.1%)
$743.67M(+3.0%)
$2.81B(-3.6%)
Sep 2014
-
$721.96M(-2.1%)
$2.92B(-0.5%)
Jun 2014
-
$737.41M(+20.5%)
$2.93B(+2.1%)
Mar 2014
-
$611.78M(-27.9%)
$2.87B(-0.8%)
Dec 2013
$2.85B(+3.2%)
$848.36M(+15.4%)
$2.90B(+5.2%)
Sep 2013
-
$735.35M(+8.4%)
$2.75B(+0.1%)
Jun 2013
-
$678.39M(+7.0%)
$2.75B(-0.5%)
Mar 2013
-
$633.96M(-10.2%)
$2.76B(+0.9%)
Dec 2012
$2.76B(+9.9%)
$706.14M(-3.4%)
$2.74B(+0.8%)
Sep 2012
-
$731.35M(+5.7%)
$2.72B(+1.8%)
Jun 2012
-
$691.71M(+13.7%)
$2.67B(+2.0%)
Mar 2012
-
$608.38M(-11.2%)
$2.62B(+1.0%)
Dec 2011
$2.51B
$684.76M(+0.3%)
$2.59B(-0.6%)
Sep 2011
-
$682.84M(+6.8%)
$2.61B(+2.7%)
Jun 2011
-
$639.34M(+9.7%)
$2.54B(+2.0%)
DateAnnualQuarterlyTTM
Mar 2011
-
$582.63M(-16.8%)
$2.49B(-0.3%)
Dec 2010
$2.51B(+13.8%)
$700.33M(+14.0%)
$2.49B(+3.6%)
Sep 2010
-
$614.08M(+4.2%)
$2.41B(+1.9%)
Jun 2010
-
$589.15M(+0.0%)
$2.36B(+2.7%)
Mar 2010
-
$589.13M(-4.0%)
$2.30B(+5.8%)
Dec 2009
$2.21B(+6.1%)
$613.74M(+7.7%)
$2.17B(+6.3%)
Sep 2009
-
$569.62M(+8.1%)
$2.04B(-12.7%)
Jun 2009
-
$526.90M(+13.8%)
$2.34B(-1.4%)
Mar 2009
-
$462.86M(-4.6%)
$2.38B(-0.5%)
Dec 2008
$2.08B(+7.9%)
$485.20M(-44.1%)
$2.39B(-2.9%)
Sep 2008
-
$867.97M(+55.1%)
$2.46B(+18.6%)
Jun 2008
-
$559.51M(+17.6%)
$2.07B(+4.3%)
Mar 2008
-
$475.91M(-14.5%)
$1.99B(+1.5%)
Dec 2007
$1.93B(+18.8%)
$556.61M(+15.5%)
$1.96B(+6.6%)
Sep 2007
-
$481.87M(+1.5%)
$1.84B(+2.5%)
Jun 2007
-
$474.57M(+6.3%)
$1.79B(+5.8%)
Mar 2007
-
$446.31M(+2.6%)
$1.69B(+9.0%)
Dec 2006
$1.62B(+33.4%)
$434.82M(-0.5%)
$1.56B(+8.5%)
Sep 2006
-
$436.98M(+16.1%)
$1.43B(+11.1%)
Jun 2006
-
$376.30M(+22.6%)
$1.29B(+6.2%)
Mar 2006
-
$306.94M(-1.9%)
$1.21B(+1.4%)
Dec 2005
$1.22B(+12.8%)
$312.95M(+6.7%)
$1.20B(+1.1%)
Sep 2005
-
$293.29M(-2.5%)
$1.18B(+1.9%)
Jun 2005
-
$300.92M(+3.9%)
$1.16B(+2.8%)
Mar 2005
-
$289.64M(-3.3%)
$1.13B(+1.8%)
Dec 2004
$1.08B(+11.9%)
$299.42M(+10.2%)
$1.11B(+2.1%)
Sep 2004
-
$271.60M(+0.7%)
$1.09B(+1.2%)
Jun 2004
-
$269.66M(-0.0%)
$1.07B(+1.5%)
Mar 2004
-
$269.70M(-2.4%)
$1.06B(+3.2%)
Dec 2003
$964.05M(+7.3%)
$276.40M(+6.9%)
$1.03B(-9.6%)
Sep 2003
-
$258.53M(+1.9%)
$1.13B(-7.4%)
Jun 2003
-
$253.68M(+7.1%)
$1.23B(-2.1%)
Mar 2003
-
$236.88M(-38.6%)
$1.25B(+1.0%)
Dec 2002
$898.39M(-6.5%)
$385.82M(+10.7%)
$1.24B(+48.4%)
Sep 2002
-
$348.61M(+24.2%)
$835.11M(+15.8%)
Jun 2002
-
$280.59M(+25.0%)
$721.27M(+2.0%)
Mar 2002
-
$224.46M(+1310.1%)
$707.03M(+0.3%)
Dec 2001
$960.88M(+5.2%)
-$18.55M(-107.9%)
$704.91M(-32.3%)
Sep 2001
-
$234.78M(-11.9%)
$1.04B(-8.5%)
Jun 2001
-
$266.35M(+19.8%)
$1.14B(+16.7%)
Mar 2001
-
$222.33M(-30.2%)
$976.25M(+18.1%)
Dec 2000
$913.67M(-41.4%)
$318.44M(-4.1%)
$826.76M(-37.8%)
Sep 2000
-
$332.06M(+221.1%)
$1.33B(+17.1%)
Jun 2000
-
$103.41M(+42.0%)
$1.14B(-2.6%)
Mar 2000
-
$72.84M(-91.1%)
$1.17B(-44.2%)
Dec 1999
$1.56B(+98.9%)
$821.58M(+496.2%)
$2.09B(+352.6%)
Sep 1999
-
$137.81M(+2.8%)
-$828.09M(-594.8%)
Jun 1999
-
$134.04M(-86.6%)
-$119.18M(-119.2%)
Mar 1999
-
$998.45M(+147.6%)
$621.98M(+22.6%)
Dec 1998
$784.20M(+20.6%)
-$2.10B(-347.8%)
$507.36M(-85.6%)
Sep 1998
-
$846.72M(-3.3%)
$3.51B(+1.8%)
Jun 1998
-
$875.19M(-1.0%)
$3.45B(+2.2%)
Mar 1998
-
$883.84M(-2.5%)
$3.38B(+2.3%)
Dec 1997
$650.46M(+130.6%)
$906.36M(+15.4%)
$3.30B(+37.9%)
Sep 1997
-
$785.25M(-2.0%)
$2.39B(+48.8%)
Jun 1997
-
$801.67M(-0.6%)
$1.61B(+99.4%)
Mar 1997
-
$806.50M
$806.50M
Dec 1996
$282.04M
-
-

FAQ

  • What is Fresenius Medical Care AG annual EBITDA?
  • What is the all-time high annual EBITDA for Fresenius Medical Care AG?
  • What is Fresenius Medical Care AG annual EBITDA year-on-year change?
  • What is Fresenius Medical Care AG quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Fresenius Medical Care AG?
  • What is Fresenius Medical Care AG quarterly EBITDA year-on-year change?
  • What is Fresenius Medical Care AG TTM EBITDA?
  • What is the all-time high TTM EBITDA for Fresenius Medical Care AG?
  • What is Fresenius Medical Care AG TTM EBITDA year-on-year change?

What is Fresenius Medical Care AG annual EBITDA?

The current annual EBITDA of FMS is $3.44B

What is the all-time high annual EBITDA for Fresenius Medical Care AG?

Fresenius Medical Care AG all-time high annual EBITDA is $4.33B

What is Fresenius Medical Care AG annual EBITDA year-on-year change?

Over the past year, FMS annual EBITDA has changed by -$20.25M (-0.59%)

What is Fresenius Medical Care AG quarterly EBITDA?

The current quarterly EBITDA of FMS is $1.00B

What is the all-time high quarterly EBITDA for Fresenius Medical Care AG?

Fresenius Medical Care AG all-time high quarterly EBITDA is $1.19B

What is Fresenius Medical Care AG quarterly EBITDA year-on-year change?

Over the past year, FMS quarterly EBITDA has changed by +$214.40M (+27.27%)

What is Fresenius Medical Care AG TTM EBITDA?

The current TTM EBITDA of FMS is $3.69B

What is the all-time high TTM EBITDA for Fresenius Medical Care AG?

Fresenius Medical Care AG all-time high TTM EBITDA is $4.53B

What is Fresenius Medical Care AG TTM EBITDA year-on-year change?

Over the past year, FMS TTM EBITDA has changed by +$247.92M (+7.20%)
On this page